These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1065 related articles for article (PubMed ID: 26424679)

  • 21. Impact of valvuloarterial impedance on 2-year outcome of patients undergoing transcatheter aortic valve implantation.
    Katsanos S; Yiu KH; Clavel MA; Rodés-Cabau J; Leong D; van der Kley F; Ajmone Marsan N; Bax JJ; Pibarot P; Delgado V
    J Am Soc Echocardiogr; 2013 Jul; 26(7):691-8. PubMed ID: 23669595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of low flow on the outcome of high-risk patients undergoing transcatheter aortic valve replacement.
    Le Ven F; Freeman M; Webb J; Clavel MA; Wheeler M; Dumont É; Thompson C; De Larochellière R; Moss R; Doyle D; Ribeiro HB; Urena M; Nombela-Franco L; Rodés-Cabau J; Pibarot P
    J Am Coll Cardiol; 2013 Aug; 62(9):782-8. PubMed ID: 23770162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.
    Osten MD; Feindel C; Greutmann M; Chamberlain K; Meineri M; Rubin B; Mezody M; Ivanov J; Butany J; Horlick EM
    Catheter Cardiovasc Interv; 2010 Mar; 75(4):475-85. PubMed ID: 19937781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treating the patients in the 'grey-zone' with aortic valve disease: a comparison among conventional surgery, sutureless valves and transcatheter aortic valve replacement.
    Muneretto C; Bisleri G; Moggi A; Di Bacco L; Tespili M; Repossini A; Rambaldini M
    Interact Cardiovasc Thorac Surg; 2015 Jan; 20(1):90-5. PubMed ID: 25320140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.
    Lefèvre T; Colombo A; Tchétché D; Latib A; Klugmann S; Fajadet J; De Marco F; Maisano F; Bruschi G; Bijuklic K; Nava S; Weissman N; Low R; Thomas M; Young C; Redwood S; Mullen M; Yap J; Grube E; Nickenig G; Sinning JM; Hauptmann KE; Friedrich I; Lauterbach M; Schmoeckel M; Davidson C; Schofer J
    JACC Cardiovasc Interv; 2016 Jan; 9(1):68-75. PubMed ID: 26762913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of surgical aortic valve replacement for severe aortic stenosis: Incorporation of left ventricular systolic function and stroke volume index.
    Parikh R; Goodman AL; Barr T; Sabik JF; Svensson LG; Rodriguez LL; Lytle BW; Grimm RA; Griffin BP; Desai MY
    J Thorac Cardiovasc Surg; 2015 Jun; 149(6):1558-66.e1. PubMed ID: 25869085
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Self-Expanding Transcatheter Aortic Valve Replacement in Patients With Low-Gradient Aortic Stenosis.
    Chetcuti SJ; Deeb GM; Popma JJ; Yakubov SJ; Grossman PM; Patel HJ; Casale A; Dauerman HL; Resar JR; Boulware MJ; Dries-Devlin JL; Li S; Oh JK; Reardon MJ
    JACC Cardiovasc Imaging; 2019 Jan; 12(1):67-80. PubMed ID: 30448116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Self-expanding transcatheter aortic valve replacement using alternative access sites in symptomatic patients with severe aortic stenosis deemed extreme risk of surgery.
    Reardon MJ; Adams DH; Coselli JS; Deeb GM; Kleiman NS; Chetcuti S; Yakubov SJ; Heimansohn D; Hermiller J; Hughes GC; Harrison JK; Khabbaz K; Tadros P; Zorn GL; Merhi W; Heiser J; Petrossian G; Robinson N; Maini B; Mumtaz M; Lee JS; Gleason TG; Resar J; Conte J; Watson D; Chenoweth S; Popma JJ;
    J Thorac Cardiovasc Surg; 2014 Dec; 148(6):2869-76.e1-7. PubMed ID: 25152474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of Prosthesis-Patient Mismatch on Left Ventricular Myocardial Mechanics After Transcatheter Aortic Valve Replacement.
    Poulin F; Yingchoncharoen T; Wilson WM; Horlick EM; Généreux P; Tuzcu EM; Stewart W; Osten MD; Woo A; Thavendiranathan P
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results of the REPRISE II Study.
    Meredith IT; Walters DL; Dumonteil N; Worthley SG; Tchétché D; Manoharan G; Blackman DJ; Rioufol G; Hildick-Smith D; Whitbourn RJ; Lefèvre T; Lange R; Müller R; Redwood S; Feldman TE; Allocco DJ; Dawkins KD
    JACC Cardiovasc Interv; 2016 Feb; 9(4):376-384. PubMed ID: 26892084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Outcomes of transcatheter aortic valve replacement in patients with chronic liver disease.
    Shah AM; Ogbara J; Herrmann HC; Fox Z; Kadakia M; Anwaruddin S; Bavaria JE; Desai ND; Jagasia D; Szeto WY; Li RH; Vallabhajosyula P; Giri J
    Catheter Cardiovasc Interv; 2015 Nov; 86(5):888-94. PubMed ID: 25963625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prosthesis-patient mismatch after transcatheter aortic valve implantation using the Edwards SAPIEN™ prosthesis.
    Van Linden A; Kempfert J; Blumenstein J; Rastan A; Holzhey D; Lehmann S; Mohr FW; Walther T
    Thorac Cardiovasc Surg; 2013 Aug; 61(5):414-20. PubMed ID: 22791205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of transcatheter aortic valve implantation in patients with reduced ejection fraction.
    Ayhan H; Kasapkara HA; Durmaz T; Keleş T; Aslan AN; Sarı C; Baştuğ S; Bilen E; Bayram NA; Akçay M; Bozkurt E
    Cardiol J; 2015; 22(1):108-14. PubMed ID: 24846516
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transcatheter Aortic Valve Implantation in Patients With Paradoxical Low-Flow, Low-Gradient Aortic Stenosis.
    Rodriguez-Gabella T; Nombela-Franco L; Auffret V; Asmarats L; Islas F; Maes F; Ferreira-Neto AN; Paradis JM; Dumont E; Côté M; Jiménez-Quevedo P; Macaya C; Pibarot P; Rodés-Cabau J
    Am J Cardiol; 2018 Aug; 122(4):625-632. PubMed ID: 30064863
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transapical transcatheter aortic valve implantation: follow-up to 3 years.
    Ye J; Cheung A; Lichtenstein SV; Nietlispach F; Albugami S; Masson JB; Thompson CR; Munt B; Moss R; Carere RG; Jamieson WR; Webb JG
    J Thorac Cardiovasc Surg; 2010 May; 139(5):1107-13, 1113.e1. PubMed ID: 20412948
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 'Paradoxical' low-flow, low-gradient severe aortic valve stenosis: an entity with limited improvement following transcatheter aortic valve implantation.
    Reinthaler M; Schwabe A; Landmesser U; Chung R; Aggarwal S; Delahunty N; Fröhlich G; Meier P; Roberts N; Pantazis A; Mullen MJ
    J Heart Valve Dis; 2014 Jul; 23(4):441-9. PubMed ID: 25803970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors of mortality and outcomes of therapy in low-flow severe aortic stenosis: a Placement of Aortic Transcatheter Valves (PARTNER) trial analysis.
    Herrmann HC; Pibarot P; Hueter I; Gertz ZM; Stewart WJ; Kapadia S; Tuzcu EM; Babaliaros V; Thourani V; Szeto WY; Bavaria JE; Kodali S; Hahn RT; Williams M; Miller DC; Douglas PS; Leon MB
    Circulation; 2013 Jun; 127(23):2316-26. PubMed ID: 23661722
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcome and Impact of Aortic Valve Replacement in Patients With Preserved LVEF and Low-Gradient Aortic Stenosis.
    Dayan V; Vignolo G; Magne J; Clavel MA; Mohty D; Pibarot P
    J Am Coll Cardiol; 2015 Dec; 66(23):2594-2603. PubMed ID: 26670058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evolution and prognostic impact of low flow after transcatheter aortic valve replacement.
    Le Ven F; Thébault C; Dahou A; Ribeiro HB; Capoulade R; Mahjoub H; Urena M; Nombela-Franco L; Allende Carrera R; Clavel MA; Dumont É; Dumesnil J; De Larochellière R; Rodés-Cabau J; Pibarot P
    Heart; 2015 Aug; 101(15):1196-203. PubMed ID: 25999587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TAVI in patients with low-flow low-gradient aortic stenosis-short-term and long-term outcomes.
    Steffen J; Reißig N; Andreae D; Beckmann M; Haum M; Fischer J; Theiss H; Braun D; Orban M; Rizas K; Sadoni S; Näbauer M; Peterss S; Hausleiter J; Massberg S; Deseive S
    Clin Res Cardiol; 2022 Dec; 111(12):1325-1335. PubMed ID: 35320407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.